ArticleOncoimmunology2021
Infliximab for the treatment of patients with checkpoint inhibitor-associated acute tubular interstitial nephritis.
Jamie S Lin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
32 papers cite it
this paperpooled itcites it